Cancer survival 'to double in 10 years' - PressReader
Using imaging to predict and improve responses to immunotherapy - Oracle Cancer Trust
The ICR on Twitter: "We were delighted to welcome @JonAshworth (MP & Shadow Health Secretary) to visit us today with @CRUK_Policy to meet Professor Kevin Harrington and team. Jon saw some of
Professor Kevin Harrington - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London
Scientists reveal new lines of attack to raise cancer survival rate | Cancer research | The Guardian
Kevin Harrington - Reader in Biological Cancer Therapies - Institute of Cancer Research | LinkedIn
Cancer: Scientists aim to double survival within a decade | The Independent
The ICR on Twitter: "Professor Kevin Harrington specialises in #HeadAndNeckCancer. He and his team study the use of biologically targeted agents, in combination with treatments such as #Radiotherapy and #Chemotherapy, to target #
ICR calls for improved biomarker cancer tests to help personalise treatment - PMLiVE
Professor Kevin Harrington - The Institute of Cancer Research, London
Prof Kevin Harrington | Events | Imperial College London
SAB and I-O AB - T3 Pharma
The ICR on Twitter: "Professor Kevin Harrington introduces our world-leading work on #immunotherapy, and how we are finding new ways to tackle melanomas, head and neck, and other cancers #partneringtodefeatcancer https://t.co/Q2nRhOW9c7" /
Using Viruses to Treat Cancer | Prof Kevin Harrington | #SCIPEL 2015 | SCI - YouTube
The ICR on Twitter: "We were delighted to welcome @JonAshworth (MP & Shadow Health Secretary) to visit us today with @CRUK_Policy to meet Professor Kevin Harrington and team. Jon saw some of
Professor Kevin Harrington - The Institute of Cancer Research, London
The ICR on Twitter: "ICR's Professor Kevin Harrington speaks about the @NICEcomms news about immunotherapy #nivolumab https://t.co/pRd7KUmAmR #CancerDrugsFund https://t.co/ompikxJVHr" / Twitter
The ICR on Twitter: "Watch Professor Kevin Harrington on @BBCLondonNews as he shares more on how a modified version of the herpes virus could offer hope for some people with advanced #Cancer.
Skin cancer: below the surface | The Royal Marsden
Get A-Head Visit The Institute of Cancer Research - Get Ahead
The ICR on Twitter: "🧬 The ICR's Professor Kevin Harrington and his team are using viral #Immunotherapy to harness the body's immune system to kill cancer. See their research with T-VEC, a
Royal Marsden researchers named among world's most influential scientists | The Royal Marsden
Loop | Kevin Joseph Harrington
